Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Press conference on the identification of existing drugs in Japan

Photo shows Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Press conference on the identification of existing drugs in Japan

The photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo taking off his mask for explanation. (March 18, 2020, Yasuda Auditorium, University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Press conference on the identification of existing drugs in Japan

Scene of the press conference. (From right) Kohei Miyazono, Executive Vice President for Research at the University of Tokyo, Makoto Gogami, President of the University of Tokyo, Yuji Yamanashi, Director of the Institute of Medical Science at the University of Tokyo, and Junichiro Inoue, Professor of the Institute of Medical Science at the University of Tokyo. (From right to left: Dr. Kohei Miyazono, Vice President for Research, The University of Tokyo; Dr. Yuji Yamanashi, Director, Institute of Medical Science, The University of Tokyo; and Dr. Junichiro Inoue, Professor, Institute of Medical Science, The University of Tokyo.

E

Press conference on the identification of existing drugs in Japan

Photo shows Makoto Gogami, President of the University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Press conference on the identification of existing drugs in Japan

Photo shows Makoto Gogami, President of the University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Press conference on the identification of existing drugs in Japan

Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Press conference on the identification of existing drugs in Japan

Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Press conference on the identification of existing drugs in Japan

(From right) Makoto Gogami, President of the University of Tokyo, Yuji Yamanashi, Director of the Institute of Medical Science of the University of Tokyo, and Junichiro Inoue, Professor of the Institute of Medical Science of the University of Tokyo, wearing masks at the press conference. The University of Tokyo's Yasuda Auditorium, Bunkyo Ward, Tokyo, March 18, 2020.

E

Press conference on the identification of existing drugs in Japan

Scene of the press conference. (From right) Makoto Gogami, President of the University of Tokyo, Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, and Junichiro Inoue, Professor of the Institute of Medical Science, University of Tokyo. The University of Tokyo Yasuda Auditorium, Bunkyo-ku, Tokyo, March 18, 2020.

E

Press conference on the identification of existing drugs in Japan

Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Press conference on the identification of existing drugs in Japan

Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, wearing a mask at the press conference. (March 18, 2020, Yasuda Auditorium, University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Press conference on the identification of existing drugs in Japan

Photo shows Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Press conference on the identification of existing drugs in Japan

Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Press conference on the identification of existing drugs in Japan

Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Press conference on the identification of existing drugs in Japan

Photo shows Kohei Miyazono, Executive Vice President (Research) of the University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

Professor Inoue of University of Tokyo, announce the identification of a new coronavirus drug candidate

Professor Junichiro Inoue and his colleagues at the University of Tokyo's Institute of Medical Science held a press conference on April 18 and announced that they had identified nafamostat. Nafamostat has been used for more than 30 years in Japan, and early clinical trials are expected to be conducted. The clinical research is expected to start by the beginning of April in cooperation with the National Center for Global Health and Medicine and others. When the new corona infects humans, proteins on the surface of the virus and proteins on the surface of human cells bind to each other, causing the outer membrane of the virus to fuse with the membrane of human cells. As a result, ribonucleic acid (RNA), which is the genetic information of the new corona, enters the human cell, and the virus multiplies. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)